Welcome to ULS!
Welcome to ULS!
> Products > Research Areas > Inflammation/Immunology
Products
Inflammation/Immunology

Chemical structure

Cat.No.

Product Name

CAS no.

Target

  • YN480068 FT011 1001288-58-9

    FT011 is an anti-fibrotic agent, reduces mRNA expression of collagens I and III and inhibits collagen synthesis.

  • YN484067 PSMα3 1001405-52-2

    PSMα3 is a peptide for manipulating DCs to become tolerogenic for DC vaccination strategies. PSMα3 penetrates and modulates human monocyte-derived DCs by altering the TLR2- or TLR4-induced maturation, inhibiting pro- ...

  • YN371078 GNF362 1003019-41-7

    GNF362 is a selective, potent, and orally bioavailable inhibitor ofinositol trisphosphate 3’ kinase B (Itpkb)with an IC50 of 9nM. GNF362 also inhibits Itpka and Itpkc with IC50 values of 20nM and 19nM, respectively. ...

  • YN320015 CR4056 1004997-71-0

    CR4056 is a selective inhibitor of human recombinant MAO-Awith an IC50 of 202.7nM. CR4056 is also a lig and ofimidazoline-2 receptor(I2R) with an IC50 of 596nM.

  • YN360375 Asivatrep 1005168-10-4

    Asivatrep (PAC-14028) is a potent and selective transient receptor potential vanilloid type I (TRPV1) antagonist.

  • YN320271 MK-2894 1006036-87-8

    MK-2894 is a potent, selective, orally active and high affinity (Ki=0.56nM) full antagonist againstE prostanoid receptor 4 (EP4 receptor)(IC50=2.5nM). MK-2894 possesses potent anti-inflammatory activity in animal models of pai...

  • YN320272 MK-2894 sodium salt 1006036-88-9

    MK-2894 sodium salt is a potent, selective, orally active and high affinity (Ki=0.56nM) full antagonist againstE prostanoid receptor 4 (EP4 receptor)(IC50=2.5nM). MK-2894 sodium salt possesses potent anti-inflammatory activity...

  • YN350124 p38 MAPK-IN-1 1006378-90-0

    p38 MAPK-IN-1 (Compound 4) is a novel potent and selective inhibitor ofp38 MAPKwith IC50 of 68nM. p38 MAPK-IN-1 shows sustained levels, low clearance and good bioavailability.

  • YN260251 Maleimide-DOTA 1006711-90-5

    Maleimide-DOTA is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

  • YN370446 Razuprotafib 1008510-37-9

    Razuprotafib, a proteintyrosine phosphatase ß (HPTPß)inhibitor, extracted from patent WO2019165349A1, compound AA34, has an IC50 of 50nM. Razuprotafib is effective for activation of Tie-2, and is protective against acute ...

  • YN1710023 IRAK inhibitor 4 1012104-68-5

    IRAK inhibitor 4 is an interleukin-1 receptor associated kinase 4(IRAK4) inhibitor.

  • YN1710022 IRAK inhibitor 3 1012343-93-9

    IRAK inhibitor 3 is an interleukin-1 (IL-I) receptor-associated kinase (IRAK) kinase modulator extracted from patent WO2008030579 A2.

  • YN370257 ML-030 1013750-77-0

    ML-030 is a potentPDE4inhibitor, with IC50 of 6.7nM, 12.9nM, 48.2nM, 37.2nM, 452nM and 49.2nM for PDE4A, PDE4A1, PDE4B1, PDE4B2, PDE4C1, and PDE4D2, respectively.

  • YN370058 Avadomide 1015474-32-4

    Avadomide(CC-122), a new chemical entity termed pleiotropic pathway modifier, is a novel agent for Diffuse large B-cell lymphoma(DLBCL) with antitumor and immunomodulatory activity. Its molecular target is the protein cereblon (C...

  • YN360095 Gefapixant 1015787-98-0

    Gefapixant (AF-219, MK-7264, R1646, RG-1646, RO 4926219) is an orally active small molecule antagonist of human P2X3 receptor with IC50 of about 30 nM, 100–250 nM for recombinant hP2X3 homotrimers and hP2X2/3 heterotrim...

  • YN371046 RV01 1016897-10-1

    RV01 is an analogue of resveratrol, inhibits DNA damage, reducesacetaldehyde dehydrogenase 2 (ALDH2)mRNA expression induced by ethanol, and exhibits hydroxyl radical scavenging activity. RV01 decreasesiNOSexpression, with...

  • YN321558 Pirfenidone D5 1020719-62-3

    Pirfenidone D5 (AMR69 D5) is a deuterium labeled Pirfenidone. Pirfenidone is an antifibrotic agent that attenuatesCCL2 and CCL12production in fibrocyte cells. Pirfenidone has growth-inhibitory effect and reducesTGF-β2pr...

  • YN440244 Fostamatinib Disodium 1025687-58-4

    R788 (Fostamatinib) disodium, a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM in a cell-free assay, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 3.

  • YN300053 Lifitegrast 1025967-78-5

    Lifitegrast is a novel small molecule integrin antagonist that inhibits a specific T cell-mediated inflammatory pathway involved in the pathogenesis of DED.

  • YN320145 VUF10460 1028327-66-3

    VUF10460 is a non-imidazole histamineH4receptor agonist; binds to rat H4 receptor with a pKi of 7.46.

    Contact

    TELL : +86-020-82000279

    Email: sales@ubiochem.com

    Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.

ULS products are chemical reagents for Research Use Only!Copyright © 2020-2021 ULS. All Rights Reserved.备案号:粤ICP备2021013238号-2
4.053896s